Bukwang Pharmaceutical Co (XKRX:003000) Future 3-5Y EPS without NRI Growth Rate : N/A (As of May. 12, 2025)

View and export this data going back to 1988. Start your Free Trial

What is Bukwang Pharmaceutical Co Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Bukwang Pharmaceutical Co's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of Bukwang Pharmaceutical Co's Future 3-5Y EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Bukwang Pharmaceutical Co's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bukwang Pharmaceutical Co's Future 3-5Y EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bukwang Pharmaceutical Co's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Bukwang Pharmaceutical Co's Future 3-5Y EPS without NRI Growth Rate falls into.

Save Embed

;

Save Embed

;

Bukwang Pharmaceutical Co (XKRX:003000) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Bukwang Pharmaceutical Co Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Bukwang Pharmaceutical Co's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Bukwang Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bukwang Pharmaceutical Co Ltd (XKRX:003000) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Traded in Other Exchanges

N/A

Address

398-1 Daebang-Dong, Dongjak-Gu, Seoul, KOR

Website

http://www.bukwang.co.kr

Bukwang Pharmaceutical Co Ltd manufactures and markets medicines for diabetes, hepatitis B, anticancer and psychiatry. The Company's OTC products focus on dental treatment. The company also engages in venture business and bio engineering.

Bukwang Pharmaceutical Co Headlines

No Headlines